Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease
Status:
Unknown status
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
This clinical study is a double-blind, randomized, placebo-controlled trial to investigate
the effects of melatonin on the sleep disturbance symptoms of Parkinson's disease patients,
symptoms which have a significant impact on the quality of life of these patients.